Breast Cancer

The CURE® Poetry Contest winners explain what inspired each of their poems, from the death of a friend and oncologist who treated one survivor’s cancer to the emotional experience of losing hair during treatment.

Coronary artery disease was far more common in young women with breast cancer who had radiation to their left breast than in those who had it to their right.

A woman describes how caring for her mother, who has stage 4 metastatic breast cancer, drastically changed her life and her priorities.

A mother and cancer caregiver expresses her frustration over the lack of breast cancer screening in young women and explains how catching cancer early saved her daughter’s life.

The eligible age of 65 years for Medicare may be discouraging patients from getting screenings and tests as they wait for more health coverage.

The overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.

From Senator Amy Klobuchar’s breast cancer experience to a 14-year-old survivor’s charity work for other children with cancer, here’s what’s happening in the cancer landscape this week.

A male breast cancer survivor asks, “How far are we willing to go for our cause?” He describes the advocacy work of two women who lost loved ones to male breast cancer.

Moderate-to-vigorous exercise before and during chemotherapy for breast cancer may help with cancer-related cognitive decline, highlighting the importance of physical activity throughout treatment.

One expert suggests that the FDA approval process of cancer drugs should remain but be on a case-by-case basis.

Women who receive a score about their genetic risk for breast cancer may not be as anxious or stressed about their results, although women with higher genetic scores may display some of these emotions.

Women with breast cancer may benefit from statin therapy after diagnosis, but more research is needed, one study reported.

Tecentriq plus chemotherapy did not meet the determined progression-free survival goal, so Genentech – the manufacturer of the immunotherapy agent – decided to pull the indication.

CURE spoke with Maimah Karmo, founder and CEO of the Tigerlily Foundation, about support after a breast cancer diagnosis.

CURE spoke with Maimah Karmo, founder and CEO of the Tigerlily Foundation, about aspects outside of breast cancer treatment, like financial toxicity, psychosocial effects and more.

CURE spoke with Maimah Karmo, founder and CEO of the Tigerlily Foundation, about disparities in breast cancer care, and how they are being addressed.

On behalf of TigerLilly Foundation, CURE spoke with Dr. Andrea Phillips about clinical trials in breast cancer.

On behalf of TigerLilly Foundation, CURE spoke with Dr. Angelique Richardson, from UCSD Health, about HER2-positive breast cancer.

A breast cancer survivor expresses her emotions in a poem about all that cancer has taken from her.

Patients with breast cancer are advised to get regular sleep, exercise often, stay hydrated and eat healthy and nutritious foods to prevent “highly debilitating” headaches, according to an expert from Stanford University School of Medicine.

Twelve weeks of acupuncture treatment in certain patients with early-stage breast cancer resulted in a long-term reduction of pain levels.

Latasha Jordan and Aditya Bardia, M.D., MPH, share advice for patients and caregivers on the importance of a positive outlook and attitude when living with triple-negative breast cancer.

A triple-negative breast cancer (TNBC) survivor, Latasha Jordan, considers the positive impact her support network has had on her treatment; and Aditya Bardia, M.D., MPH, emphasizes the importance of social support systems for patients with TNBC.

Latasha Jordan discusses her experience in a clinical trial with sacituzumab govitecan and comments on the side effects she experienced as well as the overall impact on her quality of life.

An expert oncologist highlights the importance of discussing clinical trial options with patients and comments on the recent FDA approval of sacituzumab govitecan in triple-negative breast cancer based on the ASCENT 3 trial.